Standard

Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase. / Filimonov, Aleksandr S.; Zateeva, Maria V.; Mechetin, Grigory V. и др.

в: International Journal of Molecular Sciences, Том 27, № 4, 1954, 18.02.2026.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Filimonov, AS, Zateeva, MV, Mechetin, GV, Luzina, OA, Eurtivong, C, Sari, S, Endutkin, AV, Reynisson, J, Volcho, KP, Salakhutdinov, NF & Zharkov, DO 2026, 'Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase', International Journal of Molecular Sciences, Том. 27, № 4, 1954. https://doi.org/10.3390/ijms27041954

APA

Filimonov, A. S., Zateeva, M. V., Mechetin, G. V., Luzina, O. A., Eurtivong, C., Sari, S., Endutkin, A. V., Reynisson, J., Volcho, K. P., Salakhutdinov, N. F., & Zharkov, D. O. (2026). Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase. International Journal of Molecular Sciences, 27(4), [1954]. https://doi.org/10.3390/ijms27041954

Vancouver

Filimonov AS, Zateeva MV, Mechetin GV, Luzina OA, Eurtivong C, Sari S и др. Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase. International Journal of Molecular Sciences. 2026 февр. 18;27(4):1954. doi: 10.3390/ijms27041954

Author

Filimonov, Aleksandr S. ; Zateeva, Maria V. ; Mechetin, Grigory V. и др. / Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase. в: International Journal of Molecular Sciences. 2026 ; Том 27, № 4.

BibTeX

@article{274ae99bbecc4689864fff0031d36b64,
title = "Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase",
abstract = "Tuberculosis (TB) remains a global health issue exacerbated by spreading drug resistance and lengthy treatment regimens. Targeting bacterial DNA-repair pathways, particularly those counteracting host-generated genotoxic stress, represents a promising strategy to sensitize Mycobacterium tuberculosis to existing antibiotics. Through structure-based virtual screening of a compound library, we identified novel small-molecule inhibitors of M. tuberculosis uracil–DNA glycosylase (MtbUng), an enzyme essential for the repair of DNA damage inflicted by macrophage-produced reactive nitrogen species. Experimental validation revealed that four derivatives of usnic acid, a lichen-derived metabolite, significantly inhibited MtbUng activity, with the most potent compound, OL10-88-1, exhibiting IC50 26 ± 7 µM. Molecular docking suggests that OL10-88-1 inhibits MtbUng by occupying both the active site and the DNA-binding groove, thereby disrupting multiple steps of uracil recognition. The compounds also showed variable inhibitory activity against uracil–DNA glycosylases from Escherichia coli, humans, and vaccinia virus. Our findings establish that the compound could potentially be used in combination therapies to enhance the efficacy of current anti-TB drugs by exploiting the vulnerability of DNA-repair-deficient mycobacteria.",
keywords = "DNA glycosylases, DNA repair, Mycobacterium tuberculosis, inhibitors, uracil–DNA glycosylase, usnic acid, virtual screening, репарация ДНК, ДНК-гликозилазы, урацил-ДНК-гликозилаза, Mycobacterium tuberculosis, ингибиторы, усниновая кислота, виртуальный скрининг",
author = "Filimonov, {Aleksandr S.} and Zateeva, {Maria V.} and Mechetin, {Grigory V.} and Luzina, {Olga A.} and Chatchakorn Eurtivong and Suat Sari and Endutkin, {Anton V.} and J{\'o}hannes Reynisson and Volcho, {Konstantin P.} and Salakhutdinov, {Nariman F.} and Zharkov, {Dmitry O.}",
note = "Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase / A. S. Filimonov, M. V. Zateeva, G. V. Mechetin [et al.] // International Journal of Molecular Sciences. – 2026. – Vol. 27, No. 4. – P. 1954. – DOI 10.3390/ijms27041954. – EDN DJVQGR. This research was funded by the Russian Ministry of Science and Higher Education (121031300056-8, MtbUng biochemistry; FWUE-2025-0006, compounds synthesis) and the Russian Science Foundation (21-64-00017p, biochemistry of other glycosylases).",
year = "2026",
month = feb,
day = "18",
doi = "10.3390/ijms27041954",
language = "English",
volume = "27",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

RIS

TY - JOUR

T1 - Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase

AU - Filimonov, Aleksandr S.

AU - Zateeva, Maria V.

AU - Mechetin, Grigory V.

AU - Luzina, Olga A.

AU - Eurtivong, Chatchakorn

AU - Sari, Suat

AU - Endutkin, Anton V.

AU - Reynisson, Jóhannes

AU - Volcho, Konstantin P.

AU - Salakhutdinov, Nariman F.

AU - Zharkov, Dmitry O.

N1 - Usnic Acid Derivatives as Inhibitors of Mycobacterium tuberculosis Uracil–DNA Glycosylase / A. S. Filimonov, M. V. Zateeva, G. V. Mechetin [et al.] // International Journal of Molecular Sciences. – 2026. – Vol. 27, No. 4. – P. 1954. – DOI 10.3390/ijms27041954. – EDN DJVQGR. This research was funded by the Russian Ministry of Science and Higher Education (121031300056-8, MtbUng biochemistry; FWUE-2025-0006, compounds synthesis) and the Russian Science Foundation (21-64-00017p, biochemistry of other glycosylases).

PY - 2026/2/18

Y1 - 2026/2/18

N2 - Tuberculosis (TB) remains a global health issue exacerbated by spreading drug resistance and lengthy treatment regimens. Targeting bacterial DNA-repair pathways, particularly those counteracting host-generated genotoxic stress, represents a promising strategy to sensitize Mycobacterium tuberculosis to existing antibiotics. Through structure-based virtual screening of a compound library, we identified novel small-molecule inhibitors of M. tuberculosis uracil–DNA glycosylase (MtbUng), an enzyme essential for the repair of DNA damage inflicted by macrophage-produced reactive nitrogen species. Experimental validation revealed that four derivatives of usnic acid, a lichen-derived metabolite, significantly inhibited MtbUng activity, with the most potent compound, OL10-88-1, exhibiting IC50 26 ± 7 µM. Molecular docking suggests that OL10-88-1 inhibits MtbUng by occupying both the active site and the DNA-binding groove, thereby disrupting multiple steps of uracil recognition. The compounds also showed variable inhibitory activity against uracil–DNA glycosylases from Escherichia coli, humans, and vaccinia virus. Our findings establish that the compound could potentially be used in combination therapies to enhance the efficacy of current anti-TB drugs by exploiting the vulnerability of DNA-repair-deficient mycobacteria.

AB - Tuberculosis (TB) remains a global health issue exacerbated by spreading drug resistance and lengthy treatment regimens. Targeting bacterial DNA-repair pathways, particularly those counteracting host-generated genotoxic stress, represents a promising strategy to sensitize Mycobacterium tuberculosis to existing antibiotics. Through structure-based virtual screening of a compound library, we identified novel small-molecule inhibitors of M. tuberculosis uracil–DNA glycosylase (MtbUng), an enzyme essential for the repair of DNA damage inflicted by macrophage-produced reactive nitrogen species. Experimental validation revealed that four derivatives of usnic acid, a lichen-derived metabolite, significantly inhibited MtbUng activity, with the most potent compound, OL10-88-1, exhibiting IC50 26 ± 7 µM. Molecular docking suggests that OL10-88-1 inhibits MtbUng by occupying both the active site and the DNA-binding groove, thereby disrupting multiple steps of uracil recognition. The compounds also showed variable inhibitory activity against uracil–DNA glycosylases from Escherichia coli, humans, and vaccinia virus. Our findings establish that the compound could potentially be used in combination therapies to enhance the efficacy of current anti-TB drugs by exploiting the vulnerability of DNA-repair-deficient mycobacteria.

KW - DNA glycosylases

KW - DNA repair

KW - Mycobacterium tuberculosis

KW - inhibitors

KW - uracil–DNA glycosylase

KW - usnic acid

KW - virtual screening

KW - репарация ДНК

KW - ДНК-гликозилазы

KW - урацил-ДНК-гликозилаза

KW - Mycobacterium tuberculosis

KW - ингибиторы

KW - усниновая кислота

KW - виртуальный скрининг

UR - https://www.mendeley.com/catalogue/018d3bb4-4acf-3564-9820-a2c8255bc4d5/

UR - https://www.scopus.com/pages/publications/105031480288

UR - https://elibrary.ru/item.asp?id=89835501

U2 - 10.3390/ijms27041954

DO - 10.3390/ijms27041954

M3 - Article

C2 - 41752090

VL - 27

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 4

M1 - 1954

ER -

ID: 85508887